<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000367477">
  <TermName>lobradimil</TermName>
  <TermPronunciation>(loh-BRAY-dih-mil)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that is being studied for its ability to help other drugs reach the brain. It belongs to the family of drugs called bradykinin agonists. Also called RMP-7.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000731319" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;lobradimil&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000731318" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;lobradimil&quot;" language="es" id="_4"/>
  <SpanishTermName>lobradimil</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio por su capacidad de ayudar a que otros medicamentos lleguen al cerebro. Es un tipo de agonista de la bradicinina. Tambi√©n se llama RMP-7.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2004-04-23</DateFirstPublished>
</GlossaryTerm>
